Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-21 | Candel Therapeutics, Inc. | Tak Paul Peter
(Chief Executive Officer) |
M | Common Stock | A | 12900 | $1.55 - $1.55 | $19,995 |
| 2024-11-06 | Candel Therapeutics, Inc. | Aguilar Laura K.
(AtLeastTenPercentOwner) |
D | CADL | D | 45000 | $4.92 - $5.33 | $231,600 |
| 2024-10-30 | Candel Therapeutics, Inc. | Aguilar Laura K.
(AtLeastTenPercentOwner) |
D | CADL | D | 42000 | $5.27 - $5.38 | $223,110 |
| 2024-10-24 | Candel Therapeutics, Inc. | Aguilar Laura K.
(AtLeastTenPercentOwner) |
D | CADL | D | 30929 | $5.53 - $5.80 | $172,279 |
| 2024-10-11 | Candel Therapeutics, Inc. | Aguilar Laura K.
(AtLeastTenPercentOwner) |
S | CADL | D | 40412 | $6.02 - $6.05 | $243,834 |
| 2024-10-01 | Candel Therapeutics, Inc. | Aguilar Laura K.
(AtLeastTenPercentOwner) |
S | CADL | A | 35002 | $6.85 - $7.01 | $242,640 |
| 2024-07-17 | Candel Therapeutics, Inc. | Tyagarajan Seshu
(Chief Technology Officer) |
S | Common Stock | D | 14851 | $6.47 - $6.47 | $96,124 |
| 2024-07-17 | Candel Therapeutics, Inc. | Tak Paul Peter
(Chief Executive Officer) |
S | Common Stock | D | 22528 | $6.47 - $6.47 | $145,814 |
| 2024-07-17 | Candel Therapeutics, Inc. | Schoch Charles
(See Remarks) |
S | Common Stock | D | 9884 | $6.47 - $6.47 | $63,975 |
| 2024-07-17 | Candel Therapeutics, Inc. | Nichols William G...
(Chief Medical Officer) |
S | Common Stock | D | 10875 | $6.47 - $6.47 | $70,389 |
| 2024-07-17 | Candel Therapeutics, Inc. | Barone Francesca
(Chief Scientific Officer) |
S | Common Stock | D | 14051 | $6.47 - $6.47 | $90,946 |
| 2024-07-11 | Candel Therapeutics, Inc. | Tyagarajan Seshu
(Chief Technology Officer) |
S | Common Stock | D | 13330 | $5.97 - $5.97 | $79,625 |
| 2024-07-11 | Candel Therapeutics, Inc. | Tak Paul Peter
(Chief Executive Officer) |
S | Common Stock | D | 20293 | $5.97 - $5.97 | $121,218 |
| 2024-07-11 | Candel Therapeutics, Inc. | Schoch Charles
(See Remarks) |
S | Common Stock | D | 8897 | $5.97 - $5.97 | $53,145 |
| 2024-07-11 | Candel Therapeutics, Inc. | Nichols William G...
(Chief Medical Officer) |
S | Common Stock | D | 9769 | $5.97 - $5.97 | $58,354 |
| 2024-07-11 | Candel Therapeutics, Inc. | Barone Francesca
(Chief Scientific Officer) |
S | Common Stock | D | 12645 | $5.97 - $5.97 | $75,533 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |